131:(LPDs) refer to several conditions in which lymphocytes are produced in excessive quantities. They typically occur in patients who have compromised immune systems. This subset is sometimes incorrectly equated with "immunoproliferative disorders".
241:
226:
1337:
306:
1081:
299:
635:
752:
292:
1342:
1151:
354:
1365:
717:
1107:
446:
17:
797:
1310:
1349:
895:
774:
640:
875:
673:
1299:
973:
527:
1146:
965:
516:
1294:
1250:
870:
668:
552:
1198:
909:
1141:
124:. The first is cellular, and the other two are humoral (however, humoral excess can be secondary to cellular excess.)
439:
194:
1406:
1102:
369:
1332:
1324:
1183:
1061:
1000:
986:
880:
821:
658:
584:
88:
that are characterized by the abnormal proliferation of the primary cells of the immune system, which includes
1380:
1290:
1240:
1136:
865:
649:
113:
1272:
1178:
1161:
969:
523:
432:
1213:
1086:
792:
1128:
388:
376:
174:
1016:
857:
779:
1218:
1046:
256:
684:
1235:
1112:
1091:
1005:
786:
405:
284:
117:
1244:
834:
807:
728:
630:
327:
148:(IgM), and some types are caused by a deficiency in the other major types of immunoglobulins.
424:
1041:
653:
564:
472:
348:
8:
841:
625:
595:
381:
245:
1305:
144:
in the blood serum. Five different hypergammaglobulinemias are caused by an excess of
1385:
1036:
1025:
815:
705:
620:
365:
55:
1055:
250:
158:
is the presence of excessive amounts of a single monoclonal gammaglobulin (called a
1155:
934:
802:
701:
413:
360:
344:
145:
928:
923:
732:
616:
482:
477:
331:
261:
195:
http://www.use.hcn.com.au/subject.%60Immunoproliferative%20Disorders%60/home.html
121:
1375:
393:
141:
101:
97:
1400:
1282:
981:
890:
846:
663:
537:
85:
235:
885:
547:
339:
193:
Health
Communication Network. Immunoproliferative disorders - Topic Tree.
559:
218:
455:
77:
64:
60:
267:
1370:
459:
318:
68:
272:
112:
These disorders are subdivided into three main classes, which are
314:
918:
230:
93:
89:
741:
606:
590:
454:
1204:
1098:
1082:
Non-mycosis fungoides CD30â cutaneous large T-cell lymphoma
1077:
995:
737:
712:
692:
688:
575:
493:
488:
27:
Overproduction of primary immune system cells or antibodies
944:
939:
829:
208:
1152:Peripheral T-cell lymphoma not otherwise specified
974:Precursor T acute lymphoblastic leukemia/lymphoma
528:Precursor B acute lymphoblastic leukemia/lymphoma
1398:
718:Nodular lymphocyte predominant Hodgkin lymphoma
100:(NK) cells, or by the excessive production of
1108:Secondary cutaneous CD30+ large-cell lymphoma
440:
300:
798:Post-transplant lymphoproliferative disorder
753:immunoproliferative immunoglobulin disorders
1311:Diffuse infiltrative lymphocytosis syndrome
1350:Jessner lymphocytic infiltrate of the skin
896:Primary cutaneous follicle center lymphoma
641:Primary cutaneous follicle center lymphoma
447:
433:
307:
293:
876:Primary cutaneous marginal zone lymphoma
674:Primary cutaneous marginal zone lymphoma
140:is characterized by increased levels of
1338:with bandlike and perivascular patterns
1300:Autoimmune lymphoproliferative syndrome
14:
1399:
1147:Enteropathy-associated T-cell lymphoma
428:
288:
1295:X-linked lymphoproliferative disease
187:
1251:Large granular lymphocytic leukemia
871:Intravascular large B-cell lymphoma
24:
25:
1418:
204:
1103:CD30+ cutaneous T-cell lymphoma
1333:Cutaneous lymphoid hyperplasia
1325:Cutaneous lymphoid hyperplasia
1184:Adult T-cell leukemia/lymphoma
1062:Adult T-cell leukemia/lymphoma
1001:Anaplastic large-cell lymphoma
881:Primary cutaneous immunocytoma
822:Splenic marginal zone lymphoma
13:
1:
1381:Lymphoproliferative disorders
1291:Lymphoproliferative disorders
1241:Extranodal NK-T-cell lymphoma
1113:Lymphomatoid papulosis type A
1092:Lymphomatoid papulosis type B
1006:Lymphomatoid papulosis type A
866:Diffuse large B-cell lymphoma
370:Waldenström macroglobulinemia
180:
129:Lymphoproliferative disorders
114:lymphoproliferative disorders
82:immunoproliferative disorders
49:Immunoproliferative neoplasms
18:Immunoproliferative disorders
1273:Acute biphenotypic leukaemia
1162:Subcutaneous T-cell lymphoma
104:(also known as antibodies).
45:Immunoproliferative diseases
36:Immunoproliferative disorder
7:
1214:Aggressive NK-cell leukemia
1087:Pleomorphic T-cell lymphoma
793:Lymphomatoid granulomatosis
168:
10:
1423:
175:Myeloproliferative disease
107:
1358:
1323:
1281:
1263:
1227:
1197:
1170:
1125:
1070:
1024:
1015:
955:
917:
908:
856:
766:
727:
683:
605:
574:
536:
515:
504:
471:
467:
403:
326:
212:
54:
40:
35:
1366:Hematological malignancy
1219:Blastic NK cell lymphoma
1047:Granulomatous slack skin
803:Classic Hodgkin lymphoma
702:Classic Hodgkin lymphoma
1407:Immune system disorders
406:hypergammaglobulinemia
197:. Accessed March 2007.
138:Hypergammaglobulinemia
118:hypergammaglobulinemia
1245:Angiocentric lymphoma
835:AIDS-related lymphoma
659:Splenic marginal zone
156:monoclonal gammopathy
84:are disorders of the
1343:with nodular pattern
1042:Pagetoid reticulosis
654:marginal zone B-cell
349:Plasma cell leukemia
842:Helicobacter pylori
669:Nodal marginal zone
596:Hairy cell leukemia
462:and related disease
394:Primary amyloidosis
382:Heavy chain disease
316:Immunoproliferative
1386:Lymphoid leukemias
1306:Leukemoid reaction
1142:Angioimmunoblastic
808:Burkitt's lymphoma
1394:
1393:
1319:
1318:
1259:
1258:
1193:
1192:
1121:
1120:
1037:Mycosis fungoides
904:
903:
762:
761:
706:Nodular sclerosis
621:follicular B cell
422:
421:
366:Macroglobulinemia
282:
281:
74:
73:
30:Medical condition
16:(Redirected from
1414:
1156:Lennert lymphoma
1022:
1021:
953:
952:
915:
914:
780:Primary effusion
513:
512:
502:
501:
469:
468:
449:
442:
435:
426:
425:
414:Cryoglobulinemia
345:Multiple myeloma
309:
302:
295:
286:
285:
210:
209:
198:
191:
146:immunoglobulin M
33:
32:
21:
1422:
1421:
1417:
1416:
1415:
1413:
1412:
1411:
1397:
1396:
1395:
1390:
1354:
1315:
1277:
1265:
1255:
1223:
1202:
1189:
1166:
1127:
1117:
1066:
1011:
959:
957:
932:
927:
921:
900:
852:
758:
735:
723:
679:
617:germinal center
601:
570:
532:
508:
506:
486:
481:
475:
463:
453:
423:
418:
399:
322:
313:
283:
278:
277:
221:
207:
202:
201:
192:
188:
183:
171:
162:) in the blood.
152:Paraproteinemia
142:immunoglobulins
122:paraproteinemia
110:
102:immunoglobulins
31:
28:
23:
22:
15:
12:
11:
5:
1420:
1410:
1409:
1392:
1391:
1389:
1388:
1383:
1378:
1376:Leukemia cutis
1373:
1368:
1362:
1360:
1356:
1355:
1353:
1352:
1347:
1346:
1345:
1340:
1329:
1327:
1321:
1320:
1317:
1316:
1314:
1313:
1308:
1303:
1297:
1287:
1285:
1279:
1278:
1276:
1275:
1269:
1267:
1261:
1260:
1257:
1256:
1254:
1253:
1248:
1231:
1229:
1225:
1224:
1222:
1221:
1216:
1210:
1208:
1195:
1194:
1191:
1190:
1188:
1187:
1174:
1172:
1168:
1167:
1165:
1164:
1159:
1149:
1144:
1139:
1133:
1131:
1123:
1122:
1119:
1118:
1116:
1115:
1110:
1105:
1095:
1094:
1089:
1084:
1074:
1072:
1068:
1067:
1065:
1064:
1056:SĂ©zary disease
1050:
1049:
1044:
1039:
1030:
1028:
1019:
1013:
1012:
1010:
1009:
1003:
991:
990:
987:Prolymphocytic
977:
963:
961:
950:
949:
948:
942:
912:
906:
905:
902:
901:
899:
898:
893:
888:
883:
878:
873:
868:
862:
860:
854:
853:
851:
850:
838:
826:
825:
824:
812:
811:
810:
805:
800:
795:
783:
770:
768:
764:
763:
760:
759:
757:
756:
747:
745:
725:
724:
722:
721:
709:
698:
696:
681:
680:
678:
677:
671:
666:
661:
645:
644:
638:
633:
628:
612:
610:
603:
602:
600:
599:
587:
585:Prolymphocytic
581:
579:
572:
571:
569:
568:
556:
543:
541:
534:
533:
531:
521:
519:
510:
499:
498:
497:
465:
464:
452:
451:
444:
437:
429:
420:
419:
417:
416:
410:
408:
401:
400:
398:
397:
385:
373:
357:
352:
342:
336:
334:
324:
323:
319:immunoglobulin
312:
311:
304:
297:
289:
280:
279:
276:
275:
264:
253:
238:
222:
217:
216:
214:
213:Classification
206:
205:External links
203:
200:
199:
185:
184:
182:
179:
178:
177:
170:
167:
166:
165:
164:
163:
149:
132:
109:
106:
98:natural killer
72:
71:
58:
52:
51:
42:
38:
37:
29:
26:
9:
6:
4:
3:
2:
1419:
1408:
1405:
1404:
1402:
1387:
1384:
1382:
1379:
1377:
1374:
1372:
1369:
1367:
1364:
1363:
1361:
1357:
1351:
1348:
1344:
1341:
1339:
1336:
1335:
1334:
1331:
1330:
1328:
1326:
1322:
1312:
1309:
1307:
1304:
1301:
1298:
1296:
1292:
1289:
1288:
1286:
1284:
1283:Lymphocytosis
1280:
1274:
1271:
1270:
1268:
1262:
1252:
1249:
1246:
1242:
1238:
1237:
1233:
1232:
1230:
1226:
1220:
1217:
1215:
1212:
1211:
1209:
1206:
1200:
1196:
1185:
1181:
1180:
1176:
1175:
1173:
1169:
1163:
1160:
1157:
1153:
1150:
1148:
1145:
1143:
1140:
1138:
1137:Hepatosplenic
1135:
1134:
1132:
1130:
1124:
1114:
1111:
1109:
1106:
1104:
1100:
1097:
1096:
1093:
1090:
1088:
1085:
1083:
1079:
1076:
1075:
1073:
1069:
1063:
1060:
1059:
1058:
1057:
1054:
1048:
1045:
1043:
1040:
1038:
1035:
1032:
1031:
1029:
1027:
1023:
1020:
1018:
1014:
1007:
1004:
1002:
998:
997:
993:
992:
988:
984:
983:
982:prolymphocyte
979:
978:
975:
971:
967:
964:
962:
954:
951:
946:
943:
941:
938:
937:
936:
930:
925:
920:
916:
913:
911:
907:
897:
894:
892:
891:Plasmacytosis
889:
887:
884:
882:
879:
877:
874:
872:
869:
867:
864:
863:
861:
859:
855:
848:
847:MALT lymphoma
844:
843:
839:
836:
832:
831:
827:
823:
820:
819:
818:
817:
813:
809:
806:
804:
801:
799:
796:
794:
791:
790:
789:
788:
784:
781:
777:
776:
772:
771:
769:
765:
755:
754:
749:
748:
746:
743:
739:
734:
730:
726:
719:
715:
714:
710:
707:
703:
700:
699:
697:
694:
690:
686:
682:
675:
672:
670:
667:
665:
662:
660:
656:
655:
651:
650:marginal zone
647:
646:
642:
639:
637:
634:
632:
629:
627:
623:
622:
618:
614:
613:
611:
608:
604:
597:
593:
592:
588:
586:
583:
582:
580:
577:
573:
566:
562:
561:
557:
554:
550:
549:
545:
544:
542:
539:
535:
529:
525:
522:
520:
518:
514:
511:
503:
500:
495:
492:
491:
490:
484:
479:
474:
470:
466:
461:
457:
450:
445:
443:
438:
436:
431:
430:
427:
415:
412:
411:
409:
407:
402:
395:
391:
390:
386:
383:
379:
378:
374:
371:
367:
363:
362:
358:
356:
353:
350:
346:
343:
341:
338:
337:
335:
333:
329:
325:
320:
317:
310:
305:
303:
298:
296:
291:
290:
287:
274:
270:
269:
265:
263:
259:
258:
254:
252:
248:
247:
243:
239:
237:
233:
232:
228:
224:
223:
220:
215:
211:
196:
190:
186:
176:
173:
172:
161:
157:
153:
150:
147:
143:
139:
136:
135:
133:
130:
127:
126:
125:
123:
119:
115:
105:
103:
99:
95:
91:
87:
86:immune system
83:
79:
70:
66:
62:
59:
57:
53:
50:
46:
43:
39:
34:
19:
1234:
1177:
1171:By infection
1052:
1051:
1033:
994:
980:
958:development/
886:Plasmacytoma
840:
828:
814:
785:
773:
767:By infection
750:
711:
648:
615:
589:
558:
548:naive B cell
546:
507:development/
387:
375:
359:
340:Plasmacytoma
315:
266:
255:
240:
225:
189:
159:
155:
151:
137:
128:
111:
81:
75:
48:
44:
1053:aggressive:
1026:MF+variants
565:Mantle cell
560:mantle zone
389:light chain
377:heavy chain
160:paraprotein
41:Other names
1129:peripheral
626:Follicular
456:Leukaemias
181:References
78:immunology
65:hematology
61:Immunology
1264:Lymphoid+
1034:indolent:
1017:Cutaneous
858:Cutaneous
636:GCB DLBCL
631:Burkitt's
460:lymphomas
321:disorders
273:127071007
268:SNOMED CT
56:Specialty
1401:Category
1371:leukemia
929:leukemia
924:lymphoma
483:leukemia
478:lymphoma
169:See also
134:Humoral
69:oncology
1359:General
1266:myeloid
1228:T or NK
1199:NK cell
553:CLL/SLL
262:D007160
108:Classes
94:T cells
90:B cells
1203:(most
1179:HTLV-1
1071:Non-MF
960:marker
933:(most
919:T cell
591:CD11c+
509:marker
487:(most
473:B cell
404:Other
120:, and
67:, and
1126:Other
996:CD30+
742:CD138
713:CD20+
607:CD79a
1205:CD56
1099:CD30
1078:CD30
966:TdT+
910:T/NK
775:KSHV
751:see
738:CD38
729:PCDs
693:CD30
689:CD15
664:MALT
576:CD22
517:TdT+
494:CD20
489:CD19
355:MGUS
328:PCDs
257:MeSH
246:9-CM
96:and
1236:EBV
1101:+:
1080:-:
970:ALL
945:CD8
940:CD4
935:CD3
830:HIV
816:HCV
787:EBV
691:+,
538:CD5
524:ALL
361:IgM
251:203
242:ICD
236:C88
227:ICD
154:or
76:In
47:or
1403::
968::
956:By
744:+)
740:+/
733:PP
695:+)
685:RS
505:By
458:,
332:PP
271::
260::
249::
234::
231:10
116:,
92:,
80:,
63:,
1302:)
1293:(
1247:)
1243:/
1239:(
1207:)
1201:/
1186:)
1182:(
1158:)
1154:(
1008:)
999:(
989:)
985:(
976:)
972:(
947:)
931:)
926:,
922:(
849:)
845:(
837:)
833:(
782:)
778:(
736:(
731:/
720:)
716:(
708:)
704:(
687:(
676:)
657:(
652:/
643:)
624:(
619:/
609:+
598:)
594:(
578:+
567:)
563:(
555:)
551:(
540:+
530:)
526:(
496:)
485:)
480:,
476:(
448:e
441:t
434:v
396:)
392:(
384:)
380:(
372:)
368:/
364:(
351:)
347:(
330:/
308:e
301:t
294:v
244:-
229:-
219:D
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.